Investors
Latest results
From quarterly updates to key announcements, here you can access all GSK investor-related information.
Scroll to explore
We’re confident in our future
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.
Latest announcements and results
Speeches and presentations
Dividend and share price
Explore our innovation stories
Remission could be possible for people with severe asthma, giving them a new outlook on life
Vaccinations are not just for children: why adult immunisation is a health and economic necessity
‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women
‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know
Age-related decline in immunity: why does it matter and what can be done about it?
‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development
The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact
Harnessing tumour DNA to detect cancer recurrence earlier
Antibiotic resistance: now’s the time to prevent the next pandemic
Shareholder information
Shareholder information
